By KIM BELLARD The most (unintentionally) amusing story I read this week was Tim Higgin’s Wall Street Journal article Alex Karp Is Saying What Every Angry CEO Is Thinking About AI. Dr. Karp (yes, he has a Ph.D.), co-founder and CEO of Palantir Technologies, is upset about how AI companies are using relationships with their…
Scrub Typhus Table of Contents Scrub Typhus: Symptoms, Causes, Treatment, and Prevention It starts like any other fever. You wake up with body aches, a headache that won’t go away, and a temperature that keeps rising. You assume it’s the seasonal flu, maybe dengue, or just exhaustion from the changing weather. A few tablets later,…
Fairview Health Services turned a $315 million annual loss into a nearly $600 million turnaround in just two years. At the AHA Leadership Summit, CEO James Hereford broke down the strategy behind the comeback, from workforce redesign to frontline-driven process fixes. The post How Fairview Health Services Turned Around a $315M Loss appeared first on…
The Coalition Against Surprise Medical Billing launched a campaign opposing the No Surprises Act Enforcement Act, arguing it would worsen IDR process abuse. The post Coalition Urges Policymakers to Reject No Surprises Act Enforcement Bill appeared first on MedCity News.
Do Medicare Advantage enrollees like plans with more prior authorization? On the one han, one would think the answer is a clear ‘no’. However, higher levels of prior authorization could result in lower premiums, a tradeoff many enrollees may prefer. A paper by Marr, Trivedi and Meyers (2026) aims to answer the question using beneficiary…
Spero Therapeutics enters immunology with an antibody licensed from Innovent Biologics. The lead indication is a rare autoimmune condition where Spero aims to offer advantages over the Amgen drug that is currently the only approved treatment. The post After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset appeared first on MedCity…
Matching the right patient to the right therapy now requires understanding what’s driving the apnea, not just how often it occurs. Closing that gap means rethinking what sleep apnea testing identifies and where it happens. The post Why the Next Era of Sleep Medicine Depends on Better Diagnostics appeared first on MedCity News.
It usually tracks some version of value delivered, where more customers lead to more usage and more revenue. However, in healthcare, the blind pursuit of revenue can cause real harm. The post Revenue Is a Misleading KPI in Healthcare appeared first on MedCity News.
VO2 Max Test Table of Contents What It Is, How It Works, Benefits, and Cost in India We’ve all seen people who seem to have endless stamina, effortlessly running distances while barely working up a sweat. On the other hand, some of us feel winded after a short climb. The difference often lies in VO2…
The PBM reform efforts are directional, not temporary. Meeting these expectations requires automated systems that can reconstruct claim logic on demand and provide real-time alignment between pricing, rebates and financial outputs. The post Pharmacy Benefit Operations Infrastructure Must Rise to Regulatory Reform Standards appeared first on MedCity News.